Home
/
TANDEM DIABETES CARE INC
/
Financials
/
Quarterly
TANDEM DIABETES CARE INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that TANDEM DIABETES CARE INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$249.25M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$240.68M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$234.42M
Apr 30, 2025
Q3
2025
Sep 30, 2024
$243.97M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$221.91M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$191.67M
Apr 30, 2025
Q3
2024
Sep 30, 2023
$185.62M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$195.92M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$169.38M
May 2, 2024
Q3
2023
Sep 30, 2022
$204.55M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$200.26M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$175.91M
May 3, 2023
Q3
2022
Sep 30, 2021
$179.63M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$172.14M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$141.04M
May 4, 2022
Q3
2021
Sep 30, 2020
$123.60M
Nov 3, 2021
Q2
2021
Jun 30, 2020
$109.24M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$97.93M
May 5, 2021
Q3
2020
Sep 30, 2019
$94.66M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$93.26M
Jul 30, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$27.28M
Apr 26, 2018
Q3
2017
Sep 30, 2017
$27.00M
Oct 26, 2017
Q2
2017
Jun 30, 2017
$21.33M
Jul 27, 2017
Q1
2018
Mar 31, 2017
$18.98M
Apr 26, 2018
Q3
2017
Sep 30, 2016
$12.29M
Oct 26, 2017
Q2
2017
Jun 30, 2016
$22.99M
Jul 27, 2017
Q1
2017
Mar 31, 2016
$20.06M
Apr 27, 2017
Q3
2016
Sep 30, 2015
$15.72M
Nov 1, 2016
Q2
2016
Jun 30, 2015
$15.71M
Jul 28, 2016
Q1
2016
Mar 31, 2015
$12.31M
Apr 28, 2016
Q3
2015
Sep 30, 2014
$13.51M
Oct 29, 2015
Q2
2014
Jun 30, 2014
$10.25M
Jul 31, 2014
Q1
2015
Mar 31, 2014
$8.07M
Apr 30, 2015
Q3
2014
Sep 30, 2013
$7.78M
Nov 6, 2014
Q2
2014
Jun 30, 2013
$5.53M
Jul 31, 2014
Q1
2014
Mar 31, 2013
$5.46M
May 6, 2014
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($21.17M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($52.40M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($130.56M)
Apr 30, 2025
Q3
2025
Sep 30, 2024
($23.25M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($30.81M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($42.72M)
Apr 30, 2025
Q3
2024
Sep 30, 2023
($32.96M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($35.78M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
($123.87M)
May 2, 2024
Q3
2023
Sep 30, 2022
($48.97M)
Nov 1, 2023
Q2
2023
Jun 30, 2022
($15.06M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($14.72M)
May 3, 2023
Q3
2022
Sep 30, 2021
$5.79M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$4.01M
Aug 3, 2022
Q1
2022
Mar 31, 2021
($5.04M)
May 4, 2022
Q3
2021
Sep 30, 2020
($9.41M)
Nov 3, 2021
Q2
2021
Jun 30, 2020
($27.11M)
Aug 4, 2021
Q1
2021
Mar 31, 2020
($14.87M)
May 5, 2021
Q3
2020
Sep 30, 2019
($2.90M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($1.51M)
Jul 30, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($22.86M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($51.81M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($120.88M)
Apr 30, 2025
Q3
2025
Sep 30, 2024
($26.09M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($30.77M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($41.68M)
Apr 30, 2025
Q3
2024
Sep 30, 2023
($31.55M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($38.81M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
($127.82M)
May 2, 2024
Q3
2023
Sep 30, 2022
($47.49M)
Nov 1, 2023
Q2
2023
Jun 30, 2022
($12.24M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($15.34M)
May 3, 2023
Q3
2022
Sep 30, 2021
$7.72M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$5.43M
Aug 3, 2022
Q1
2022
Mar 31, 2021
($3.24M)
May 4, 2022
Q3
2021
Sep 30, 2020
($1.01M)
Nov 3, 2021
Q2
2021
Jun 30, 2020
($12.04M)
Aug 4, 2021
Q1
2021
Mar 31, 2020
($13.57M)
May 5, 2021
Q3
2020
Sep 30, 2019
($6.00M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($1.87M)
Jul 30, 2020